{
  "plain_title": "Is dexmedetomidine (a calming and pain‑relief medicine) safe and effective for newborns on a breathing machine compared with other pain‑relief drugs or no medication?",
  "key_messages": [
    "We could not find any studies that compared dexmedetomidine (a calming and pain‑relief medicine) with other drugs or no medication in newborns (infants under four weeks old) who are on a breathing machine (mechanical ventilation), so we cannot say whether it is safe or effective for sedation or pain relief, and we have no information on possible harmful effects.",
    "There are four ongoing trials that plan to enrol between 40 and 200 newborns and will compare dexmedetomidine with drugs such as fentanyl, morphine, or a combination of ketamine and dexmedetomidine; these studies may soon provide data on how well the medicine works and its safety.",
    "Because of the current lack of evidence, future research needs well‑designed randomised trials that look at both short‑term benefits (sedation and analgesia) and potential harms (including low blood pressure and long‑term neurodevelopment) to determine whether dexmedetomidine should be used routinely in this vulnerable population."
  ],
  "background": [
    {
      "subheading": "Why is keeping newborns comfortable and calm a challenge when they need a breathing machine?",
      "content": "Some newborn babies need help breathing with a machine called a ventilator. While they are on the ventilator they often feel pain or become restless, so doctors give medicines to keep them calm (sedation) and free from pain (analgesia). The most common medicines are opioids such as morphine, but these can affect the baby's heart rate, blood pressure and breathing. Dexmedetomidine is a different type of drug that works by activating a specific part of the nervous system called the \"alpha‑2\" receptor (think of it as a special switch that reduces stress without strongly affecting the heart). It is being used more and more in babies, even though it is not officially approved for this purpose. Researchers want to know whether dexmedetomidine is actually effective and safe for these tiny patients."
    },
    {
      "subheading": "What did the researchers want to find out about dexmedetomidine?",
      "content": "The review set out to discover whether dexmedetomidine works better, the same, or worse than other medicines (including other non‑opioid drugs, opioids, or no drug at all) for keeping newborns on ventilators comfortable and calm. Specifically, they aimed to assess how well the drug provides sedation and pain relief, and to evaluate any safety concerns such as low blood pressure, death, or long‑term developmental effects."
    }
  ],
  "methods": [
    {
      "subheading": "Methods",
      "content": "We searched databases for studies comparing dexmedetomidine with other analgesia or sedation options (or placebo) in newborns receiving mechanical ventilation. We combined any results we found and rated the certainty of the evidence using standard methods."
    }
  ],
  "results": [
    {
      "subheading": "What did we find?",
      "content": "We found no eligible studies, so no participants were enrolled and there is no information on study duration, funding sources, population characteristics (such as age, gender, or severity), study settings, or the specific interventions and comparators. Although four ongoing trials were identified, they were not yet eligible for inclusion, and therefore no data on these characteristics are available. Consequently, we could not answer our research question."
    }
  ],
  "limitations": "We are not confident in the evidence because there are not enough studies to be certain about the results of our outcomes.",
  "currency": "The evidence is up to date to September 2023 of search."
}